Maryam Ahmadi, Ph.D.
About Maryam Ahmadi, Ph.D.
Maryam Ahmadi, Ph.D., is the Senior Director of CMC Regulatory Affairs at PsiVida, where she has worked since 2019. She holds a Doctor of Philosophy and has extensive experience in regulatory affairs and quality control within the pharmaceutical industry.
Current Role at EyePoint Pharmaceuticals
Maryam Ahmadi serves as the Senior Director of CMC Regulatory Affairs at EyePoint Pharmaceuticals. She has held this position since 2019, contributing to the company's regulatory strategies and compliance efforts. Her role involves overseeing the development and implementation of regulatory submissions and ensuring that the company's products meet all necessary quality standards.
Education and Expertise
Maryam Ahmadi earned her Doctor of Philosophy degree from the University of Connecticut, where she studied from 1990 to 1993. Prior to that, she completed her Master of Science at the same institution from 1987 to 1990. Her academic journey began with a Bachelor of Science degree from Sacred Heart University, which she obtained from 1983 to 1987. This educational background provides her with a strong foundation in scientific and regulatory principles.
Previous Experience in the Pharmaceutical Industry
Before joining EyePoint Pharmaceuticals, Maryam Ahmadi held several key positions in the pharmaceutical industry. She worked at Boehringer Ingelheim as the Manager of QCTS from 1996 to 1999 in Ridgefield, Connecticut. She also served as the Director of Quality Control at Pliva from 2002 to 2004 in East Hanover, New Jersey. These roles contributed to her extensive experience in quality control and regulatory affairs.